🔗 Share this article

An underground economy for unlicensed weight-loss drugs is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.

Investigational Drug Gaining Popularity Via Social Media

The experimental drug, which remains in research studies, is being advertised by online personalities for its alleged weight-reducing effects. Followers are urged to contact these profiles directly for source information, while also receiving discount codes.

Active Commerce on Messaging Platforms

Additionally, a robust market exists on messaging services, where communities with numerous of members share “before and after” images, administration instructions and claims of rapid UK delivery. Sellers promote the drug there before redirecting customers to WhatsApp for transactions.

Learning About Retatrutide

This medication is an experimental injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Professionals Voice Worries

However, physicians and chemists have warned that the sale of what is still an unapproved drug in the UK is a cause for concern and could lead to individuals injecting substances of unknown origin.

Several professionals said the popularity for retatrutide could be linked to the increasing cost of approved slimming products such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still violate pharmaceutical, marketing, and customer regulations, potentially leading to fines, legal action or prison.

Platform Response and Material Elimination

According to the social media company, the service has taken down violative content and banned related hashtags and search suggestions. The company said it was committed to keeping the platform secure and investing in enhancing compliance measures.

Online Trading Activities

Research also found groups with up to nine thousand participants marketing retatrutide using Telegram's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” immediately brings up groups with numerous of members, filled with images of slimming results, positive reviews and detailed instructions for mixing or injecting at residence.

Within moments of entering one community, a seller posted WhatsApp details, where most transactions occur. The seller provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one asked about weight, medical conditions or past usage.

Product Details and Pricing

Within these communities, messages show dark colored packages with postal service labels, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with purified liquid, or pre-filled injectors usually sold at 160 pounds for 20 milligrams. When asked how much time a injector should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for the messaging service said it actively moderated dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are administering substances they cannot confirm. Although the research behind retatrutide is sound, these online versions may not include what they claim,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the surge in interest to current cost increases for approved weight-loss medications such as Mounjaro. “With costs rising, patients are turning to social media. But fake treatments are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.

Her staff has already encountered patients injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be contaminated or improperly measured.”

Producer Statement

A representative from Eli Lilly said the substance was in third stage clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company investigational substance not yet approved … may expose patients to potentially serious medical dangers”.